BANK OF MONTREAL /CAN/ - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 40 filers reported holding FATE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$933,000
-59.4%
11,805
-42.5%
0.00%
-100.0%
Q4 2020$2,297,000
+1564.5%
20,514
+517.3%
0.00%
Q3 2020$138,000
-23.8%
3,323
-33.4%
0.00%
Q2 2020$181,000
+20.7%
4,988
-34.8%
0.00%
Q4 2019$150,000
+111.3%
7,656
+66.8%
0.00%
Q3 2019$71,000
-20.2%
4,589
+4.8%
0.00%
Q2 2019$89,0004,378
+43680.0%
0.00%
Q1 2019$0
-100.0%
10
-99.4%
0.00%
Q4 2018$20,000
+17.6%
1,554
+48.9%
0.00%
Q3 2018$17,000
+41.7%
1,044
+1.5%
0.00%
Q2 2018$12,000
+71.4%
1,029
+51.3%
0.00%
Q1 2018$7,000
-61.1%
680
-77.3%
0.00%
Q4 2017$18,0003,000
+17547.1%
0.00%
Q3 2017$017
+30.8%
0.00%
Q4 2016$013
-7.1%
0.00%
Q3 2016$014
-95.1%
0.00%
Q2 2016$0285
+3971.4%
0.00%
Q1 2016$07
-41.7%
0.00%
Q4 2015$012
-61.3%
0.00%
Q3 2015$031
+34.8%
0.00%
Q2 2015$0
-100.0%
23
-98.8%
0.00%
Q1 2015$10,0002,0000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$11,083,3302.77%
Redmile Group, LLC 13,169,057$43,194,5072.61%
SUPERSTRING CAPITAL MANAGEMENT LP 497,360$1,631,3412.06%
Boxer Capital, LLC 8,215,910$26,948,1851.42%
Deep Track Capital, LP 5,572,607$18,278,1510.55%
Vestal Point Capital, LP 2,000,000$6,560,0000.49%
Bruce & Co., Inc. 300,000$984,0000.32%
Octagon Capital Advisors LP 520,800$1,708,2240.27%
Integral Health Asset Management, LLC 850,000$2,788,0000.26%
Bellevue Group AG 4,839,779$15,874,4750.26%
View complete list of FATE THERAPEUTICS INC shareholders